Rabeprazole Sodium Delayed Release Tablets
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D220R0061
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
Notice text
8 versions
Update #8 · Latest ·
Amendment 0007 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets extends the closing date until April 30, 2020 at 3:00 PM DST. Submission of offers via DIBBS submittial.
Amendment 0006 supercedes Amendment 0005 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets is to allow only DIBBS submittial of offers. Any other submittial of offers is not acceptable. Closing date has been extended until April 23, 2020 at 3:00 PM DST.
Amendment 0005 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets extends the closing date until April 23, 2020 at 3:00 PM DST and to update email submissions of offers.
Amendment 0004 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 16, 2020 at 3:00 PM DST to allow email submissions of offers.
Amendment 0003 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 09, 2020 at 3:00 PM DST.
Amendment 0002 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incoproate three (3) DFARS clauses into solicitation.
Amendment 0001 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incorporate two (2) DFARS clauses into solicitation.
Solicitation for Rabeprazole Sodium DR Tablets SPE2D2-20-R-0061.
Update #7 ·
Amendment 0006 supercedes Amendment 0005 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets is to allow only DIBBS submittial of offers. Any other submittial of offers is not acceptable. Closing date has been extended until April 23, 2020 at 3:00 PM DST.
Amendment 0005 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets extends the closing date until April 23, 2020 at 3:00 PM DST and to update email submissions of offers.
Amendment 0004 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 16, 2020 at 3:00 PM DST to allow email submissions of offers.
Amendment 0003 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 09, 2020 at 3:00 PM DST.
Amendment 0002 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incoproate three (3) DFARS clauses into solicitation.
Amendment 0001 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incorporate two (2) DFARS clauses into solicitation.
Solicitation for Rabeprazole Sodium DR Tablets SPE2D2-20-R-0061.
Update #6 ·
Amendment 0005 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets extends the closing date until April 23, 2020 at 3:00 DST and to update email submissions of offers.
Amendment 0004 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 16, 2020 at 3:00 DST to allow email submissions of offers.
Amendment 0003 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 09, 2020 at 3:00 PM DST.
Amendment 0002 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incoproate three (3) DFARS clauses into solicitation.
Amendment 0001 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incorporate two (2) DFARS clauses into solicitation.
Solicitation for Rabeprazole Sodium DR Tablets SPE2D2-20-R-0061.
Update #5 ·
Amendment 0004 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 16, 2020 at 3:00 DST to allow email submissions of offers.
Amendment 0003 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 09, 2020 at 3:00 PM DST.
Amendment 0002 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incoproate three (3) DFARS clauses into solicitation.
Amendment 0001 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incorporate two (2) DFARS clauses into solicitation.
Solicitation for Rabeprazole Sodium DR Tablets SPE2D2-20-R-0061.
Update #4 ·
Amendment 0003 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets closing date extended until April 09, 2020 at 3:00 PM DST.
Amendment 0002 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incoproate three (3) DFARS clauses into solicitation.
Amendment 0001 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incorporate two (2) DFARS clauses into solicitation.
Solicitation for Rabeprazole Sodium DR Tablets SPE2D2-20-R-0061.
Update #3 ·
Amendment 0002 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incoproate three (3) DFARS clauses into solicitation.
Amendment 0001 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incorporate two (2) DFARS clauses into solicitation.
Solicitation for Rabeprazole Sodium DR Tablets SPE2D2-20-R-0061.
Update #2 ·
Amendment 0001 SPE2D2-20-R-0061 Rabeprazole Sodium DR Tablets to incorporate two (2) DFARS clauses into solicitation.
Solicitation for Rabeprazole Sodium DR Tablets SPE2D2-20-R-0061.
Update #1 ·
Solicitation for Rabeprazole Sodium DR Tablets SPE2D2-20-R-0061.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| Rabeprazole Sodium Delayed Release Tablets | Award Notice | |
| This notice | Solicitation | |
| Rabeprazole Sodium Delayed Release Tablets | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity